We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




"Skinny Scope” for Less-Risky Esophagus Screening

By HospiMedica staff writers
Posted on 04 Jan 2007
A new study reports that screening patients with chronic heartburn or pre-cancer of the esophagus in an office setting with small-caliber endoscopy is as accurate but less expensive and less risky than a traditional sedated screening in a procedure room. More...


Researchers at the Oregon Health & Science University (OHSU, Portland, USA) Digestive Health Center enrolled 134 patients with long-standing histories of gastroesophageal reflux disease (GERD) symptoms and acid-reducing medication in a randomized, cross-over trial, with 98% of the subjects successfully completing unsedated small-caliber endoscopy, using the so-called "skinny scope” in an office setting. Patients inhaled a topical anesthetic that numbed their nasal passages and throat. The clinician then passed the 4.9 mm caliber endoscope through the nose, pharynx, and throat.

More than 70% of the study participants said they would choose the unsedated skinny scope over conventional sedated upper endoscopy. They listed a number of reasons for preferring the skinny scope, including not having to undergo anesthesia, not missing a day of work, not having to arrange for transportation to and from home, and the ability to watch the entire procedure in real time on a color monitor and receive immediate feedback from the clinician. The prevalence of Barrett's esophagus discovered by both approaches was equal, and there were no undetected cases of cancer. The findings were published in the December 2006 edition of the American Journal of Gastroenterology.

"It's a more personal approach and represents the potential to eliminate the infrastructure and costs required for intravenous sedation. It's also more immediate. As soon as you're done, you can tell the patient what you've found,” said lead author Blair A. Jobe, M.D., a surgeon in the OHSU Digestive Health Center and member of the OHSU Cancer Institute.

Barrett's esophagus refers to an abnormal change (metaplasia) in the cells of the lower end of the esophagus thought to be caused by damage from GERD. Barrett's esophagus is found in about 10% of patients who seek medical care, and is considered to be a pre-malignant condition associated with an increased risk of esophageal cancer.



Related Links:
Oregon Health & Science University

Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Monitor/Defibrillator
Zenix
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.